BioSpace News Archive

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) proudly announced that the company’s subsidiary Olaregen Therapeutics’ wound conforming matrix, Excellagen, has been awarded a Blanket Purchase Agreement (BPA) contract from the National Strategic Acquisition Center (SAC) through the efforts of AvMedical, Olaregen’s Small Disabled Veteran Owned Small Distributor (SDVOSD) partner.

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), today announced that it has entered into definitive agreements with several healthcare-focused institutional investors for the purchase and sale of 1,275,000 shares of Bellerophon’s common stock, at a purchase price of $12.00 per share, in a registered direct offering priced at-the-market under Nasdaq rules.

Benitec Biopharma Limited (Benitec or the “Company”) (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announce that the Supreme Court of Queensland (“Court”) has approved the scheme of arrangement to redomicile the Benitec group from Australia to the United States of America.

Fractyl Laboratories Inc. (Fractyl) today announced clinical data that elucidate the mechanisms behind the beneficial effects and significant improvements in metabolic disease parameters for type 2 diabetes patients after one Revita® duodenal mucosal resurfacing (DMR) treatment.

US and European rare disease patient alliances, the National Organization for Rare Disorders (NORD®) and EURORDIS-Rare Diseases Europe call for the expeditious development of COVID-19 treatments without the use of orphan drug incentives

The American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) issued a joint statement on Mar 25 criticizing physicians, hospitals, and pharmacies for “inappropriately” purchasing “excessive” amounts of medicines that could potentially save lives threatened by COVID-19.

Centre for Neuro Skills (CNS), a premier provider of traumatic and acquired brain injury rehabilitation services, announced today that all patient therapy sessions will be delivered remotely via its existing telehealth technology.

The American College of Emergency Physicians is shocked and outraged by the growing reports of employers retaliating against frontline health workers who are trying to ensure they and their colleagues are protected while caring for patients in this pandemic—including an emergency physician in Washington State who was recently terminated after he spoke out about his hospital’s lack of personal protective equipment.

Destination Pet was acquired by L1 Health in 2019; LetterOne aims to build a global leader in pet health and wellness services and committed up to $450 million of capital to the effort

On March 26, a local cancer patient was the first to complete proton therapy treatment in Northern Virginia at the Inova Mather Proton Therapy Center in Fairfax.